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Inferring causal molecular networks: empirical
assessment through a community-based effort
Steven M Hill1,28, Laura M Heiser2–4,28, Thomas Cokelaer5,27, Michael Unger6,7, Nicole K Nesser8, Daniel E Carlin9,
Yang Zhang10,27, Artem Sokolov9, Evan O Paull9, Chris K Wong9, Kiley Graim9, Adrian Bivol9, Haizhou Wang10,27,
Fan Zhu11, Bahman Afsari12, Ludmila V Danilova12,13, Alexander V Favorov12–14, Wai Shing Lee12, Dane Taylor15,16,
Chenyue W Hu17, Byron L Long17, David P Noren17, Alexander J Bisberg17, HPN-DREAM Consortium18,
Gordon B Mills19, Joe W Gray2–4, Michael Kellen20, Thea Norman20, Stephen Friend20, Amina A Qutub17, Elana
J Fertig12, Yuanfang Guan11,21,22, Mingzhou Song10, Joshua M Stuart9, Paul T Spellman8, Heinz Koeppl6,7,27,
Gustavo Stolovitzky23, Julio Saez-Rodriguez5,24 & Sach Mukherjee1,25–27
It remains unclear whether causal, rather than merely
correlational, relationships in molecular networks can be
inferred in complex biological settings. Here we describe
the HPN-DREAM network inference challenge, which focused
on learning causal influences in signaling networks.
We used phosphoprotein data from cancer cell lines as well
as in silico data from a nonlinear dynamical model. Using the
phosphoprotein data, we scored more than 2,000 networks
submitted by challenge participants. The networks spanned
32 biological contexts and were scored in terms of causal
validity with respect to unseen interventional data. A number
of approaches were effective, and incorporating known biology
was generally advantageous. Additional sub-challenges
considered time-course prediction and visualization. Our results
suggest that learning causal relationships may be feasible
in complex settings such as disease states. Furthermore, our
scoring approach provides a practical way to empirically assess
inferred molecular networks in a causal sense.

Molecular networks are central to biological function, and the
data-driven learning of regulatory connections in molecular
networks has long been a key topic in computational biology1–6.
An emerging notion is that networks describing a certain biological process (e.g., signal transduction or gene regulation) may
depend on biological contexts such as cell type, tissue type and
disease state7,8. This has motivated efforts to elucidate networks
that are specific to such contexts9–14. In disease settings, networks
specific to disease contexts could improve understanding of the
underlying biology and potentially be exploited to inform rational
therapeutic interventions.
In this study we considered inference of causal molecular networks, focusing specifically on signaling downstream of receptor
tyrosine kinases. We define edges in causal molecular networks
(‘causal edges’) as directed links between nodes in which inhibition of the parent node can lead to a change in the abundance
of the child node (Fig. 1a), either by direct interaction or via
unmeasured intermediate nodes (Fig. 1b). Such edges may be
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specific to biological context (Fig. 1c). The notion of a causal
link is fundamentally distinct from a correlational link (Fig. 1d).
Causal network inference is profoundly challenging15,16, and many
methods for inferring regulatory networks connect correlated,
or mutually dependent, nodes that might not have any causal
relationship. Some approaches (e.g., directed acyclic graphs17–19)
can in principle be used to infer causal relationships, but their
success can be guaranteed only under strong assumptions 15,20
that are almost certainly violated in biological settings. This
is due to many limitations—some possibly fundamental—
in our ability to observe and perturb biological systems.
These observations imply that it is essential to undertake careful empirical assessment in order to learn whether computational
methods can provide causal insights in specific biological settings.
Network inference methods are often assessed using data simulated
from a known causal network structure (a so-called gold-standard
network5,17). Such studies (and their synthetic biology counterparts21)
are convenient and useful, but at the same time they are limited because
it is difficult to truly mimic specific biological systems of interest.
Inferred networks are often compared to the literature, but for the
purpose of learning novel, potentially context-specific, regulatory
relationships, this is an inherently limited approach, and experimental
validation of network inference methods has remained limited9,10,19,22.
With the support of the Heritage Provider Network (HPN),
we developed the HPN-DREAM challenge to assess the ability
to learn causal networks and predict molecular time-course data.
The Dialogue for Reverse Engineering Assessment and Methods
(DREAM) project23 (http://dreamchallenges.org) has run several
challenges focused on network inference22,24–27. Here we focused
on causal signaling networks in human cancer cell lines. Protein
assays were carried out using reverse-phase protein lysate arrays28,29
(RPPAs) that included functional phosphorylated proteins.
The HPN-DREAM challenge comprised three sub-challenges.
Sub-challenge 1 was to infer causal signaling networks using protein time-course data. To focus on networks specific to genetic and
epigenetic background, the task spanned 32 different contexts, each
defined by a combination of cell line and stimulus, and each with
its own training and test data. The test data were used to assess the
causal validity of inferred networks, as described below. A companion in silico data task also focused on causal networks but by
design did not allow the use of known biology. Sub-challenge 2 was
to predict phosphoprotein time-course data under perturbation.
This sub-challenge comprised both an experimental data task and
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Figure 1 | Causal networks. (a) A directed edge denotes that inhibition
of the parent node A can change the abundance of the child node B.
(b) Causal edges, as used here, may represent direct effects or indirect
effects that occur via unmeasured intermediate nodes. If node A causally
influences node B via measured node C, the causal network should contain
edges from A to C and from C to B, but not from A to B (top). However,
if node C is not measured (and is not part of the network), the causal
network should contain an edge from A to B (bottom). Note that in both
cases inhibition of node A will lead to a change in node B. (c) Causal edges
may depend on biological context; for example, a causal edge from A to B
appears in context 1, but not in context 2 (lines in graphs are as defined
in a). (d) Correlation and causation. Nodes A and B are correlated owing
to regulation by the same node (C), but in this example no sequence of
mechanistic events links A to B, and thus inhibition of A does not change
the abundance of B (lines in bottom right graph are as defined in a).
Therefore, despite the correlation, there is no causal edge from A to B.
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an in silico data task, and the same training data sets were used
as in sub-challenge 1. Sub-challenge 3 was to develop methods to
visualize these complex, multidimensional data sets.
Across all sub-challenges, the scientific community contributed 178 submissions. In the network inference sub-challenge
we found that several submissions achieved statistically significant results, providing substantive evidence that causal network
inference may be feasible in a complex, mammalian setting
(we discuss a number of relevant caveats below). The use of
pre-existing biological knowledge (e.g., from online databases)
seemed to be broadly beneficial. However, FunChisq, a method
that did not incorporate any known biology whatsoever, was not
only the top performer in the in silico data task but also highly
ranked in the experimental data task.
Challenge data, submissions and code have been made available
as a community resource through the Synapse platform30, which
was used to run the challenge (https://www.synapse.org/HPN_
DREAM_Network_Challenge; methods applied in the challenge
are described in Supplementary Notes 1–3).
RESULTS
Experimental training data
For the experimental data network inference task, participants were provided with RPPA phosphoprotein data from four
breast cancer cell lines under eight ligand stimulus conditions31.
The 32 (cell line, stimulus) combinations each defined a biological context. Data for each context comprised time courses for ~45
phosphoproteins (Supplementary Table 1). The training data
included time courses obtained under three kinase inhibitors and a
control (dimethyl sulfoxide (DMSO)) (Fig. 2a; details of the experimental design, protocol, quality control and pre-processing can be
found in the Online Methods). The data set is also available in an
interactive online platform (http://dream8.dibsbiotech.com) that
uses the Biowheel design developed by the winning team of the
visualization sub-challenge.
Participants were tasked with using the training data to learn
causal networks specific to each of the 32 contexts. Networks had
to comprise nodes corresponding to each phosphoprotein with
directed edges between the nodes. The edges were required to
have weights indicating the strength of evidence in favor of each
nature methods | VOL.13 NO.4 | APRIL 2016 | 311
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Figure 2 | The HPN-DREAM network inference
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counts and a (context-specific) AUROC. (d) In each context, teams were ranked by AUROC score, and mean rank across contexts gave the final rankings.

possible edge, but they did not need to indicate sign (i.e., whether
activating or inhibitory). For the companion in silico data task,
participants were provided with data generated from a nonlinear
differential equation model of signaling12. The task was designed
to mirror some of the key features of the experimental setup,
and participants were asked to infer a single directed, weighted
network (Online Methods and Supplementary Fig. 1). Whereas
the experimental data task tested both data-driven learning and
use of known biology, the in silico data task focused exclusively
on the former, and for that reason node labels (i.e., protein names
in the underlying model) were anonymized.
Empirical assessment of causal networks
An incorrect causal network can score very well on standard statistical assessments of goodness of fit or predictive ability; for
example, two nodes that are highly correlated but not causally
linked (Fig. 1d) may predict each other well. For the experimental
data task, we therefore developed a procedure that leveraged
interventional data to assess inferred networks in a causal sense.
The key idea was to assess the extent to which causal relationships encoded in inferred networks agreed with test data obtained
under an unseen intervention (Fig. 2a). Specifically, for a given
context c, we identified the set of nodes that showed salient
changes under a test inhibitor (here an mTOR inhibitor) relative
to the DMSO-treated control (Fig. 2b and Online Methods).
These nodes can be regarded as descendants of the inhibitor target
(mTOR) in the underlying causal network for context c. We denote
this gold-standard descendant set by DcGS (Supplementary Fig. 2).
312 | VOL.13 NO.4 | APRIL 2016 | nature methods

Note that DcGS may include both downstream nodes and those
influenced via feedback loops within the experimental time
frame. We emphasize that these ‘gold-standard’ sets are derived
from (held-out) experimental data and should not be regarded as
representing a fully definitive ground truth.
For each submitted context-specific network, we computed a
predicted set of mTOR descendants (Dcpred) and compared it with
DcGS to obtain an area under the receiver operating characteristic
curve (AUROC) score (Fig. 2c). Teams were ranked in each of the
32 contexts by AUROC score, and the mean rank across contexts
was used to provide an overall score and final ranking (Online
Methods, Fig. 2d and Supplementary Fig. 3a). We tested the
robustness of the rankings using a subsampling strategy (Online
Methods). In addition to mean ranks, we used mean AUROC scores
(across the contexts) in the analyses described below; these
scores complement the mean ranks by giving information on the
absolute level of performance, and the two metrics are highly
correlated (Supplementary Fig. 3c).
For the in silico data task, the true causal network was known
(Online Methods and Supplementary Fig. 4) and was used to
obtain an AUROC score for each participant that determined the
final rankings (Supplementary Fig. 3b).
An alternative scoring metric to AUROC is the area under
the precision-recall curve (AUPR), which is often used when
there is an imbalance between the number of positives and
negatives in the gold standard32. Some of our settings were
imbalanced, and we therefore compared rankings based on
the AUROC and AUPR, which showed reasonable agreement

MCF7

BT549

UACC812

10

b
In silico data task: AUROC

IGF1
NRG1
HGF
FGF1
Insulin
EGF
PBS
Serum
IGF1
NRG1
HGF
FGF1
Insulin
EGF
PBS
Serum
IGF1
NRG1
HGF
FGF1
Insulin
EGF
PBS
Serum
IGF1
NRG1
HGF
FGF1
Insulin
EGF
PBS
Serum

BT20

20

0.8

0.7

Did not use prior network
Used prior network
Unknown
r = 0.35
P = 0.01
9

0.6

c
Mean AUROC

40

7

3

8

2
3

6
10

0.5

0.4

30

1
3

0.4
0.5
0.6
0.7
Experimental data task: mean AUROC

0.8

0.8
0.7
0.6
0.5
0.4

50

Individual teams
Aggregate submission
10

20
30
40
50
Number of top teams aggregated

60

d 0.8
60

70

Mean AUROC

(Online Methods and Supplementary
Figs. 5 and 6).

a

Final rank

Figure 3 | Network inference sub-challenge
(SC1) results. (a) AUROC scores in each of
the 32 (cell line, stimulus) contexts for
the 74 teams that submitted networks for
the experimental data task. (b) Scores in
experimental and in silico data tasks. Each
square represents a team. Red borders around
squares indicate that a different method
was used in each task. Numbers adjacent to
squares indicate ranks for the top ten teams
under a combined score (three teams ranked
third). (c,d) Results of crowdsourcing for the
experimental data task. Aggregate networks
were formed by combining, for each context,
networks from top scoring (c) or randomly
selected (d) teams (Online Methods). Dashed
lines indicate aggregations of all submissions.
Results in d are mean values over 100 iterations
of random selection (error bars indicate ±s.d.).
(e,f) Performance by method type for the
experimental (e) and in silico (f) data tasks.
The final rank is shown above each bar,
and the gray lines indicate the mean
performance of random predictions.
ODE, ordinary differential equation.

0.7
0.6
0.5
0.4

Individual teams
Aggregate submission

Mean AUROC

Performance of individual teams and
10
20
30
40
50
60
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
ensemble networks
Number of random teams aggregated
AUROC
Across the 32 contexts included in the
experimental data network inference task
2
4
3
e 0.8 1
5
6
7 9
(Fig. 3a), a mean of 11.8 teams (s.d. = 7.3;
8
10
18
14 22
13
17
23
26
Supplementary Fig. 7 includes a full set of
29
0.6
30 33
32 36 41
37
40 4449 52
43 56 57 6153
48
5164 71
45 65
70
counts by context) achieved statistically sig0.4
nificant AUROC scores (FDR < 0.05; multiple testing correction performed within
0.2
each context with respect to the number of
0
teams; Online Methods). For the in silico
Linear
Prior
Pairwise
Ensemble
Nonlinear ODEs
Other
Bayesian
regression network
score
regression
networks
data task, the top 14 teams achieved sigonly
nificant AUROC scores (Supplementary
0.8
1
f
2
3
5 6
4
7
8 9 10
Fig. 3b). The fact that several teams
12
11
13 17
16 25
15 28 33
0.6
22 36
23
26 35 37 41
44
46 50
47
48 53
achieved significant scores with respect to
51
55 58
61
62 64
65
causal performance metrics suggests that
0.4
causal network inference may be feasible
0.2
in this setting. Supplementary Table 2
presents a summary of submissions.
0
Pairwise
Nonlinear
Other
Linear
ODEs
Ensemble
Bayesian
Scores on the experimental data and
score
regression
regression
networks
in silico data network inference tasks were
modestly correlated (r = 0.35, P = 0.011) but were better corre- in silico data task it ranked within the top five (AUROC of 0.67).
lated when only teams that did not use prior information were Combinations of as few as 25% of randomly chosen submissions
compared (r = 0.68, P = 0.002; Fig. 3b and Supplementary Note performed well on average (mean AUROCs of 0.72 and 0.64
4). To identify teams that performed well across both tasks, we for experimental and in silico data tasks, respectively; Fig. 3d
averaged ranks for experimental and in silico data tasks (Fig. 3b and Supplementary Fig. 8b).
Methodological details were provided by 41 of the 80 parand Supplementary Fig. 3d).
To test the notion of ‘crowdsourcing’22,27,33,34 for causal net- ticipating teams (Supplementary Note 1), allowing us to
work inference, we combined inferred networks across all teams classify submissions (Fig. 3e,f, Supplementary Table 2 and
(Online Methods, Fig. 3c and Supplementary Fig. 8a). For the Supplementary Note 5). Similar to previous DREAM chalexperimental data task, this ensemble or aggregate submission
lenges22,33, we observed no clear relationship between method
slightly outperformed the highest-ranked individual submis- class and performance. We note that the boundaries between
method classes are not always well defined and that additional
sion (mean AUROCs of 0.80 and 0.78, respectively), and for the
AUROC

npg

© 2016 Nature America, Inc. All rights reserved.

Analysis

nature methods | VOL.13 NO.4 | APRIL 2016 | 313

npg

a

b
P = 0.032

Network inference
method only

Aggregate
prior only

0.8

0.7

Mean AUROC

Mean AUROC

0.8

0.6

0.7
0.6
FunChisq
PropheticGranger
Random

0.5

0.5
Prior network
(n = 18)

c

0.4

No prior network
(n = 18)

BT20

1

MCF7

0
0.2
0.4
0.6
0.8
1.0
Proportion of aggregate prior contribution

BT549

UACC812

0.9
0.8

0.6

8

20

6

15

4

10

2

5

Incorporating pre-existing biological knowledge
On average, teams that used prior biological information outperformed those that did not (Fig. 4a; one-sided rank-sum test,
P = 0.032). The submission ranked second used only a prior
network and did not use the protein data. However, use of a prior
network did not guarantee good performance, with mean AUROC
scores ranging from 0.49 to 0.78 for teams using a prior network.
Interestingly, the same prior network that was itself ranked
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The best-scoring method for the experimental data task, “PropheticGranger with
heat diffusion prior,” by Team1, used a prior network created by
averaging similarity matrices. The matrices were obtained via
simulated heat diffusion applied to links derived from the Pathway
Commons database35. The prior network was then coupled with
an L1-penalized regression approach that considered not only past
but also future time points (a detailed description is presented in
Supplementary Note 1). The best scoring approach for the in silico
data network inference task, and the most consistent performer
across both data types, was the FunChisq method by Team7
(Supplementary Note 1). This approach used a novel functional
χ2 test to examine functional dependencies among the variables
and did not use any biological prior information. Before FunChisq
was applied, the abundance of each protein was discretized via the
Ckmeans.1d.dp method36, with the number of discretization levels
selected using the Bayesian information criterion on a Gaussian
mixture model.
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second was used in both the top-performing submission and the
submission ranked 43rd, the difference being the approach used
to analyze the experimental data. Conversely, not using a prior
network did not necessarily result in poor performance; mean
AUROC scores ranged from 0.49 to 0.71 for teams not using a
prior network. The top-performing teams using prior networks
in the experimental data task did not perform as well in the
in silico data task (Fig. 3b).
To further investigate the influence of known biology, we
combined submitted prior networks to form an aggregate prior
network (Online Methods). This outperformed the individual
prior networks and had a score similar to that of the aggregate submission described above (mean AUROC of 0.79).
We combined the aggregate prior network with each of the two
top methods (PropheticGranger and FunChisq) in varying proportions (Fig. 4b). Combining FunChisq with the aggregate prior
improved upon the aggregate prior alone (this was not the case for
PropheticGranger). Finally, we considered three-way combinations of PropheticGranger, FunChisq and the aggregate prior; the
highest-scoring combination consisted of 20% PropheticGranger,
50% FunChisq and 30% aggregate prior (mean AUROC of 0.82;
Supplementary Fig. 9). We set the combination weights by
optimizing performance on the test data; we note that because
additional test data were not available, we could not rigorously
assess the combination analyses.
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Figure 5 | Aggregate submission networks for the experimental data network inference task (SC1A). (a) The aggregate submission network for cell line
MCF7 under HGF stimulation. Line thickness corresponds to edge weight (number of edges shown set to equal number of nodes). To determine which edges
were present and not present in the aggregate prior network, we placed a threshold of 0.1 on edge weights. Green and blue nodes represent descendants
of mTOR in the network shown (Fig. 2b,c and Supplementary Fig. 2). The network was generated using Cytoscape40. (b) Principal component analysis
applied to edge scores for the 32 context-specific aggregate submission networks (Online Methods).

Context-specific performance
The overall score in the experimental data task was an average
over all contexts; to gain additional insight, we further investigated performance by context. In line with their good overall
performance, aggregate submission and prior performed well
relative to individual submissions in most contexts (Fig. 4c).
The aggregate prior network performed particularly well for cell
line MCF7 but less well for BT549, supporting the notion that
biological contexts differ in the extent to which they agree with
known biology. The aggregate submission offered the greatest
improvements over the aggregate prior in settings where the
aggregate prior performed less well, suggesting that combining
data-driven learning with known biology might offer the most
utility in noncanonical settings.
Crowdsourced context-specific signaling hypotheses
The context-specific aggregate submission networks (see Fig. 5a
for an example) provided crowdsourced signaling hypotheses.
Comparing the aggregate submission with the aggregate prior
network helped to highlight potentially novel edges; we have provided a list of context-specific edges with their associated scores
as a resource (Supplementary Table 3). Dimensionality reduction
suggested that differences between cell lines were more prominent than those between stimuli for a given cell line (Fig. 5b and
Online Methods), in line with the notion that (epi)genetic background has a key role in determining network architecture.
Time-course prediction sub-challenge
In the time-course prediction sub-challenge, participants
predicted phosphoprotein time courses obtained under interventions not seen in the training data (Online Methods). We
assessed predictions by direct comparison with the test data
using root-mean-square (r.m.s.) error (Online Methods and
Supplementary Note 6), focusing on predictive ability rather

than causal validity. Supplementary Table 4 and Supplementary
Note 2 present team scores and descriptions of submissions.
Testing the robustness of team ranks gave two top performers
for the experimental data task and a single top performer for the
in silico data task (Online Methods).
The two top performers for the experimental data task took
different approaches. Team42 (ranked second) simply calculated
averages of values in the training data. Team10 (ranked third)
used a truncated singular value decomposition to estimate parameters in a regression model. This method also ranked highly for the
in silico data task and was the most consistent performer across
both data types. Team44, the top-ranked team, was not eligible to
be named as a top performer because of an incomplete submission (Supplementary Note 7), but their approach also consisted
of calculating averages. The good performance of averaging may
be explained to some degree by a shortcoming with the r.m.s.
error metric used here (Supplementary Fig. 10). Team34, the
top performer for the in silico data task, used a model informed
by networks learned in the network inference sub-challenge.
This suggests that networks can also have a useful role in purely
predictive analyses.
Visualization sub-challenge
A total of 14 teams submitted visualizations that were made
available to the HPN-DREAM Consortium members, who
then voted for their favorite (Online Methods). The winning entry, Biowheel, is designed to enhance the visualization
of time-course protein data and aid in their interpretation
(Supplementary Note 3). The data associated with a cell line
are plotted to depict protein-abundance levels by color, as in a
heat map, but are displayed as a ring, or wheel. Time is plotted
along the radial axis and increases from the center outward.
The interactive tool provides a way to mine data by displaying
data subsets in various ways.
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DISCUSSION
Inferring molecular networks remains a key open problem in
computational biology. This study was motivated by the view
that empirical assessment will be essential in catalyzing the
development of effective methods for causal network inference.
Such methods will be needed to systemically link molecular networks to the phenotypes they influence. Although causal network
inference may fail for many theoretical and practical reasons, our
results, obtained via a large-scale, community effort with blinded
assessment, suggest that the task may be feasible in complex mammalian settings. By “feasible,” we mean capable of reaching a performance level significantly better than that achieved by chance,
and this was accomplished by a number of submissions, including
approaches that did not use any prior information.
Our assessment approach focuses on causal validity and is general enough to be applicable in a variety of settings, such as gene
regulatory or metabolic networks. However, it is important to take
note of several caveats. First, the procedure relies on the specificity of test inhibitors. However, if the inhibitor were highly nonspecific, it would probably not be possible to achieve good results
or for a prior network to perform well, because the predictions
themselves are based on assumed specificity. In addition, data suggest that the mTOR inhibitor used here is reasonably specific37.
Second, the procedure used only one of the inhibitors for testing,
whereas rankings could be changed by the inclusion of additional
inhibitors. Hill et al.31 used a cross-validation–type scheme that
iterated over inhibitors. Such an approach, although more comprehensive, is not possible in a ‘live’ challenge setting, as training
and test data must be fixed at the outset. Third, the procedure
does not distinguish between direct and indirect causal effects.
Finally, all downstream nodes were weighted equally, regardless of
whether they were context specific. Metrics that better emphasize
context-specific effects will be an important avenue for future
research and would probably shed further light on the utility of
priors (which are not usually context specific). We also emphasize
that further work is needed to clarify the theoretical properties of
the score used here with respect to capturing agreement with the
(unknown) ground truth.
Several submissions used novel methods or incorporated novel
adaptations of existing methods (Supplementary Tables 2 and 4).
Notably, the best-performing team for the network inference
in silico data task developed a novel procedure (FunChisq) that
also performed well on the experimental data task without use
of prior information, increasing confidence in its robustness.
Indeed, the ability to make such comparisons is a key benefit
of running experimental and in silico challenges in parallel.
Although some approaches performed well on one data type
only (Fig. 3b), the overall positive correlation between experimental and in silico scores is striking given that they were based
on different data and assessment metrics. Teams that did not use
prior information were relatively well correlated (Fig. 3b), suggesting that good performers among these teams on the in silico
data task could perform competitively on experimental data if
their methods were extended to incorporate known biology.
The observation that prior information alone performs well
reflects the fact that much is already known about signaling in
cancer cells and suggests that causal networks are not entirely
‘rewired’ in those cells. However, our analysis revealed contexts
that deviate from known biology; such deviations are likely to
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be particularly important for understanding disease-specific
dysregulation and therapeutic heterogeneity. Furthermore, it is
possible that the literature is biased toward cancer, and for that
reason priors based on the literature may be less effective in other
disease settings. We anticipate that in the future a combination
of known biology and data-driven learning will be important in
elucidating networks in specific disease states.
A previous DREAM challenge also focused on signaling networks in cancer26. However, the scoring metric was predictive
rather than causal (r.m.s. error between predicted and test data
points) with a penalty related to sparseness of the inferred network. Our assessment approach shares similarities with other
approaches in the literature, including those used by Maathuis
et al.38, who focused on inferring networks from static
observational data, and Olsen et al.39, who used a different
scoring metric, considering predicted downstream targets in
close network proximity to the inhibited node.
It remains unclear to what extent the ranking of specific submitted methods could be generalized to different data types and
biological processes. In our view, it is still too early to say whether
there could emerge broadly effective ‘out-of-the-box’ methods for
causal network inference analogous to methods used for some
tasks in statistics and machine learning. Given the complexity of
causal learning and the wide range of application-specific factors,
we recommend that at the present time network inference efforts
should whenever possible include some interventional data and
that suitable scores, such as those described in this paper, be used
for empirical assessment in the setting of interest.
Methods
Methods and any associated references are available in the online
version of the paper.
Accession codes. All data used for the challenge are available
through Synapse under ID syn1720047.
Note: Any Supplementary Information and Source Data files are available in the
online version of the paper.
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ONLINE METHODS
Challenge data. The HPN-DREAM network inference challenge
comprised three sub-challenges: causal network inference (SC1),
time-course prediction (SC2) and visualization (SC3). SC1 and
SC2 each consisted of two tasks, one based on experimental data
(SC1A and SC2A, respectively) and the other based on in silico
data (SC1B and SC2B, respectively).
Experimental data. The experimental data and associated components of the challenge are outlined in Figure 2a. Protein data
from four breast cancer cell lines (UACC812, BT549, MCF7 and
BT20) were provided for the challenge. All cell lines were acquired
from ATCC, authenticated by short tandem repeat (STR) analysis, and tested for mycoplasma contamination. These cell lines
were chosen because they represent the major subtypes of breast
cancer (basal, luminal, claudin-low and HER2-amplified) and are
known to have different genomic aberrations41–43. Each cell line
sample was treated with one of eight stimuli (serum, PBS, EGF,
insulin, FGF1, HGF, NRG1 and IGF1). We refer to each of the
32 possible combinations of cell line and stimulus as a biological
context. For each context, data consisted of time courses for total
proteins and post-translationally modified proteins, obtained
under four different kinase inhibitors and a DMSO control.
Full details of sample preparation, data generation, quality control and pre-processing steps can be found in ref. 31 and on the
Synapse30 webpage describing the challenge (https://www.synapse.org/HPN_DREAM_Network_Challenge). In brief, cell lines
were serum-starved for 24 h and then treated for 2 h with an
inhibitor (or combination of inhibitors) or DMSO vehicle alone.
Cells were then either harvested (0 time point) or stimulated by
one of the eight stimuli for 5, 15, 30 or 60 min or for 2, 4, 12, 24, 48
or 72 h before protein harvest and analysis by RPPA at the MD
Anderson Cancer Center Functional Proteomics Core Facility
(Houston, Texas).
RPPA is an antibody-based assay that provides quantitative
measurements of protein abundance 28,44. The MD Anderson
RPPA core facility maintains and updates a standard antibody
list on the basis of antibody quality control as well as a variety of
other factors, including scientific interest. Antibodies available for
use in this assay are therefore enriched for components of receptor
tyrosine kinase signaling networks and cancer-related proteins.
For each cell line, we used the standard antibody list available at
the time the assays were performed. We used 183 antibodies to
target total (n = 132), cleaved (n = 3) and phosphorylated (n =
48) proteins (the set of phosphoproteins varied slightly between
cell lines; Supplementary Table 1). As part of the RPPA pipeline,
we performed quality control to identify slides with poor antibody staining. Antibodies with poor quality control scores were
excluded from the data set. During the challenge period, it became
known to challenge organizers that several antibodies were of
poor quality. Participants were advised not to include the associated data in their analyses, and these data were excluded from the
scoring process. Measurements for each sample were corrected for
protein loading, and several outlier samples with large correction
factors were identified and removed. The UACC812 data were
split across two batches. A batch-normalization procedure was
applied31 to enable the data from the two batches to be combined.
The experimental data used in the challenge are a subset of the
data reported by Hill et al.31.

doi:10.1038/nmeth.3773

The inhibitors were chosen because they target key components of the receptor tyrosine kinase signaling cascades assessed
by the RPPA and are also relevant to breast cancer. Participants
were provided with a training data set consisting of data for four
out of the five inhibitor regimes (DMSO, PD173074 (FGFRi),
GSK690693 (AKTi), and GSK690693 + GSK1120212 (AKTi +
MEKi)). Note that there were no training data available for the
AKTi + MEKi inhibitor regime for cell lines BT549 (all stimuli)
and BT20 (PBS and NRG1 stimuli). Data for the remaining
inhibitor (AZD8055 (mTORi)) formed a test data set, unseen by
participants and used to evaluate submissions to the challenge.
The focus of the challenge was on short-term phosphoprotein
signaling events and not on medium- to long-term changes over
hours and days (for example, rewiring of networks due to epigenetic changes arising from prolonged exposure to an inhibitor).
Therefore the training data consisted only of phosphoprotein data
(~45 phosphoproteins for each cell line) up to and including the
4-h time point; in the challenge this data set was referred to as
the main data set. In case some participants found the additional
data useful, measurements for the remaining antibodies and time
points were also made available in a ‘full’ data set. The test data
(and challenge scoring) also focused only on phosphoproteins
up to and including the 4-h time point. At the time of the challenge, all data were unpublished (the training data set was made
available to participants through the Synapse platform).
In silico data. The in silico data and associated components of
the challenge are outlined in Supplementary Figure 1. Simulated
data were generated from a nonlinear ordinary differential equation (ODE) model of the ERBB signaling pathway. Specifically, the
model was an extended version of the mass action kinetics model
developed by Chen et al.12. Training data were simulated for
20 network nodes (Supplementary Fig. 4; 14 phosphoproteins,
two phospholipids, GTP-bound RAS and three dummy nodes that
were unconnected in the network) under two ligand stimuli (each
at two concentrations; applied individually and in combination)
and under three inhibitors targeting specific nodes in the network
or no inhibitor. Mirroring the experimental data, inhibitors were
applied before ligand stimulation at t = 0. Time courses consisted
of 11 time points (0, 1, 2, 4, 6, 10, 15, 30, 45, 60 and 120 min),
and three technical replicates were provided for each sample.
A measurement error model was developed to reflect the antibodybased readout of RPPAs and its technical variability. Node names
were anonymized to prevent the use of prior information to trivially reconstruct the network. Further details of the simulation
model can be found in Supplementary Note 8.
An in silico test data set was also generated to assess submissions
to the time-course prediction sub-challenge and consisted of time
courses for each node and stimulus, under in silico inhibition of each
network node in turn. After the final team rankings for the in silico
data task were calculated, two minor issues concerning the in silico
test data were discovered. The issues were corrected, test data
were regenerated, and final rankings and final leaderboards were
updated. The top-performing teams remained unchanged after this
update. Further details can be found in Supplementary Note 8.
Challenge questions and design. For the network inference
sub-challenge experimental data task, participants were asked to
use the training data to learn 32 signaling networks, one for each

nature methods

© 2016 Nature America, Inc. All rights reserved.

npg

of the (cell line, stimulus) contexts. Networks had to contain nodes
for each phosphoprotein in the training data (node sets therefore varied depending on cell line), and network edges had to be
directed (but unsigned). The networks were expected to describe
causal edges, and this was reflected in the scoring (discussed
below). A causal edge was defined as one for which inhibition of
the parent node can result in a change in the abundance of the
child node that is not fully mediated via any other measured node
(but the influence can take place via unmeasured nodes; Fig. 1).
Participants were asked to submit confidence scores (between 0
and 1) for each possible directed edge in each network. Node names
were not anonymized for the experimental data task, and participants were allowed to use pre-existing biological information
(e.g., from literature and online databases) in their analyses.
For the network inference sub-challenge in silico data task,
participants were asked to infer a single network with 20 nodes
(one for each variable in the training data) and directed edges
corresponding to predicted causal relationships between the
nodes. Submissions comprised a set of confidence scores for each
possible directed edge in the network.
For the time-course prediction sub-challenge, participants
were tasked with predicting time courses under interventions
not contained in the training data set. For the experimental data
task, predictions were requested for five test kinase inhibitors
(participants were informed of the inhibitor targets). For each
inhibitor, time courses consisting of seven time points (as in the
training data) had to be predicted for each of the 32 contexts and
for all phosphoproteins (except those targeted by the inhibitor).
The in silico data task proceeded in an analogous fashion, with
participants asked to predict time courses under inhibition of
each of the 20 nodes in turn. Predicted time courses were required
for each node for each of the eight stimulus contexts.
In the visualization sub-challenge, participants were asked to
devise novel approaches to represent the data set provided with
the challenge. The submission format was a schematic mock-up
of the visualization.
The challenge was run over a period of 3 months. For the network inference and time-course prediction sub-challenges, participants were able to make submissions and obtain feedback via
a leaderboard on a weekly basis (Supplementary Note 9). The
frequency of feedback was chosen so as to obtain a balance
between actively engaging participants and avoiding overfitting
of models to the test data. To address this overfitting issue, other
DREAM challenges34,45 used a second held-out test data set for
final scoring of submissions. However, this was not possible here
because of the small number of inhibitor conditions in the data.
As an incentive for participation, top-performing teams were
awarded a modest cash prize (provided by HPN), invitations to
present results at a conference and coauthor the paper describing
the challenge, and (for SC1A only) the opportunity to have their
method developed as a Cytoscape Cyni app39,46. Further details
can be found on the Synapse web pages describing the challenge
(https://www.synapse.org/HPN_DREAM_Network_Challenge)
and in Supplementary Note 7.
Scoring procedure for the network inference sub-challenge
experimental data task. Interventional test data. For the experimental data task, we developed a scoring procedure that used
held-out interventional data to assess the causal validity of
nature methods

networks submitted by participants. The procedure assessed the
extent to which causal relationships encoded in network submissions agreed with causal information contained in the test data.
Using the held-out mTOR inhibitor data, we identified those
phosphoproteins that showed a salient change in abundance under
the inhibitor relative to the DMSO-treated control (Fig. 2b).
Specifically, we let miD,c and miI,c denote the mean abundance levels
of phosphoprotein i for (cell line, stimulus) context c under DMSO
control conditions and mTOR inhibition, respectively (mean values were calculated over seven time points on log-transformed
data; any replicates at each time point were averaged before the
mean was taken). A paired t-test was used to assess whether miD,c
was significantly different from miI,c , resulting in a P value pic for
each phosphoprotein and context.
Some phosphoproteins show a clear stimulus response under
DMSO, characterized by a marked increase and subsequent
decrease in abundance over time (a ‘peak’ shape). In such cases,
a change in abundance due to the mTOR inhibitor may be observable only at intermediate time points. Because the paired t-test
described above considers all time points, this effect may be
masked. Therefore we used a heuristic to detect phosphoproteins
with a peak-shaped time course under DMSO and re-performed
the paired t-test over the intermediate time points within the peak
only. The resulting P value was retained if smaller than the original. For each context, a test was performed for each phosphoprotein. We corrected for multiple testing within each context using
the median adaptive linear step-up procedure47, which resulted
in q-values (FDR-adjusted P values) qic. Note that owing to the
heuristic step, qic should not be interpreted formally.
For each context, a phosphoprotein was determined to have
shown a change under the mTOR inhibitor if the following two
conditions were satisfied: (1) qic < 0.05 and (2) miD,c − miI,c > s i,c ,
where σi,c is the pooled replicate s.d. for the DMSO and mTOR
inhibitor data. The second condition acted as a conservative filter
to ensure that effect sizes were not small relative to replicate variation. We worked under the assumption that mTOR inhibition
would lead to changes in the abundance of all descendants of
mTOR in the underlying context-specific causal network (i.e.,
that changes would be observed in any node for which a directed
path existed from mTOR to that node; this included downstream
nodes as well as those influenced via feedback loops within the
timescale of the experiments). This procedure resulted in context-specific gold-standard sets of causal descendants of mTOR
DcGS = i : qi ,c < 0.05 and miD,c − miI,c > s i ,c (Supplementary Fig. 2).
The scoring metric. For each context c, we compared the goldstandard descendant set DcGS (obtained from the held-out test data)
with predicted descendant sets obtained from context-specific
networks submitted by participants (Fig. 2c). For context c,
a submitted network consisted of edge confidence scores for
each possible directed edge. Placing a threshold τ on edge scores
resulted in a network structure consisting only of those edges
with a score greater than τ, and from this network we obtained a
predicted set of descendants of mTOR (at threshold τ), denoted
by Dcpred (t ). Comparing Dcpred (t ) with DcGS gave the number of
predicted descendants that were correct (true positives; TP (τ))
and the number of predicted descendants that were incorrect
(false positives; FP(τ)). Varying the threshold τ and plotting
TP(τ) against FP(τ) resulted in a receiver operating characteristic curve, and the scoring metric was the area under this curve
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(normalized to be between zero and one; AUROC). For each team,
AUROC scores were calculated for each of the 32 contexts.
The statistical significance of AUROC scores was determined
using simulated null distributions, generated by calculating
AUROC scores for 100,000 random networks, each consisting
of random edge scores (drawn independently from the uniform
distribution on the unit interval [0,1]). Gaussian fits to the null
distributions were used to calculate P values. For each context,
the set of P values (across all teams) underwent multiple testing correction using the Benjamini-Hochberg FDR procedure.
There were two contexts (BT549, NRG1 and BT20, insulin) for
which no team achieved a statistically significant (FDR < 0.05)
AUROC score (Supplementary Fig. 7b). These two contexts were
therefore regarded as too challenging and were disregarded in the
scoring procedure.
Teams were ranked in each context according to AUROC score.
The resulting 30 rank scores for each team were then averaged
to obtain a mean rank score. Final team rankings were obtained
using mean rank scores (Fig. 2d).
During the challenge period, participants were informed only
that submitted networks would be scored using test data obtained
under interventions not present in the training data; details of the
scoring procedure and the identity, nature and number of interventions in the test data were not revealed. Note that participants
knew the identities of inhibitors in the training data.
Gold-standard network and scoring metric for the network
inference sub-challenge in silico data task. The true causal
network underlying the variables in the in silico data was
obtained from the data-generating nonlinear ODE model
(Supplementary Fig. 4). However, deriving the causal network
from the equations was not trivial because the model contained
more variables than the 20 variables present in the challenge
data and some variables appeared in the model in complexes.
Details of how the causal network was obtained can be found in
Supplementary Note 8.
Each team submitted a single network consisting of a set of edge
scores. This was compared directly to the gold-standard causal
network to produce a receiver operating characteristic curve
(by calculating the number of true positive and false positive
edges at various edge score thresholds), and the AUROC was used
as the scoring metric. Self-edges were not considered for scoring.
The statistical significance of AUROC scores was determined
analogously to the experimental data task.
Alternative scoring metrics for the network inference subchallenge. We used AUROC as the scoring metric for the network
inference sub-challenge, but we note that alternative metrics could
have been used. In particular, the AUPR is often used when there
is an imbalance between the number of positives and negatives in
the gold standard32. Although many contexts in the experimental
data task had a reasonable balance (median ratio of negatives to
positives of 1.71), some contexts had many more negatives than
positives, and there was also an imbalance for the in silico data
task (ratio of negatives to positives of 4.14; Supplementary Fig. 5).
Therefore AUPR could have been an appropriate choice in several cases. For this reason, at the end of the challenge period we
performed comparisons of final team rankings (obtained using
AUROC) to rankings obtained using AUPR or a combination of
doi:10.1038/nmeth.3773

AUROC and AUPR (Supplementary Fig. 6). For the experimental
data task, the AUROC-based rankings showed good agreement
with those obtained under either alternative metric. Agreement
was not as strong for the in silico data task, but it was still reasonable, with all metrics resulting in the same top performer.
Furthermore, of the top ten teams under AUROC, only two were
outside the top ten under AUPR, and they ranked 12th and 13th.
Similarly, only two of the top ten teams under AUPR were not
in the top ten under AUROC, and they ranked 11th and 12th.
For openness and transparency, scores and rankings based on
AUPR and the combination metric were included in the final
leaderboards (available through Synapse at https://www.synapse.
org/HPN_DREAM_Network_Challenge; combination metric
scores are also included in Supplementary Table 2).
Scoring metric for the time-course prediction sub-challenge.
For both experimental data and in silico data, predictions of
context-specific time courses under inhibitors not contained in
the training data were directly compared against context-specific
test data obtained under the corresponding inhibitor. Prediction
accuracy was quantified using r.m.s. error with comparisons made
on log-transformed data after averaging of replicates. The r.m.s.
error scores were calculated separately for parts of the data that
could potentially be on different scales. We refer to each portion
of the data where an r.m.s. error score was calculated as a ‘data
block’. Teams were ranked within each data block, and a mean
rank was calculated to obtain a final ranking. Some blocks of
data, where no team achieved a statistically significant score, were
disregarded in the scoring procedure (Supplementary Tables 5
and 6; FDR < 0.05). Full details of the scoring are presented in
Supplementary Note 6.
Visualization sub-challenge scoring. HPN-DREAM challenge
participants scored submitted visualization proposals. Thirty-six
participants cast votes by assigning ranks (from 1 to 3) to their
three favorite submissions (the remaining submissions were all
assigned a rank of 4). Teams were then ranked according to mean
rank across the 36 votes (Supplementary Fig. 11).
Robustness of ranking under subsampling. To ensure that team
rankings were robust in the network inference and time-course
prediction sub-challenges, we performed a subsampling analysis
in which, for each of 100 iterations, 50% of the test data were
removed at random and rankings of submissions were recalculated using the remaining test data. Team A was considered to be
robustly ranked above team B if the former outranked the latter
in at least 75% of iterations.
For the network inference sub-challenge experimental data
task, we subsampled test data by either (i) removing 50% of the
phosphoproteins for each (cell line, stimulus) context when making comparisons between gold-standard and predicted descendant sets (Supplementary Fig. 12a) or (ii) removing 50% of the
contexts (i.e., scoring was based on 15 contexts instead of 30;
Supplementary Fig. 12b). The top team (Team1) outranked
the team ranked second (Team2) in 76% and 97% of iterations
for subsampling methods i and ii, respectively. For the network
inference sub-challenge in silico data task, 50% of the edges (and
non-edges) in the gold-standard network were used for scoring
(Supplementary Fig. 12c). The top-scoring performer (Team7)
nature methods
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had a higher AUROC score than the team ranked second (Team11)
in 89% of the subsampling iterations.
For the experimental and in silico data tasks in the time-course
prediction sub-challenge, we subsampled test data by either (i)
removing 50% of the data blocks or (ii) subsampling 50% of the
data points within each data block. For the experimental data
task, the top-ranked team (Team44) outranked the team ranked
second (Team42) in 90% and 54% of iterations for subsampling
methods i and ii, respectively. Because the 75% threshold was
not met for one of the subsampling methods, Team44 was not
regarded as ranked robustly above Team42. Team42 outranked the
team ranked third (Team10) in 60% and 70% of iterations and so,
again, the ranking was not regarded as robust. However, Team10
was robustly ranked above the team ranked fourth (93% and 94%
of iterations). Team44 was not eligible to be named as a top performer because of an incomplete submission (Supplementary
Note 7), and so the teams ranked second and third (Team42 and
Team10, respectively) were named as top performers. For the
in silico data task, the top team (Team34) outranked the team
ranked second in 95% and 100% of iterations for subsampling
methods i and ii, respectively.
Crowdsourced analyses: aggregate submission networks and
aggregate prior network. We obtained aggregate submission networks by integrating predicted networks across all teams (to avoid
bias, we used a filtering process to remove correlated submissions
from the aggregation; 66 and 58 teams formed the aggregate networks for the experimental and in silico data tasks, respectively;
Supplementary Note 10 and Supplementary Table 2). For the
experimental data task, an aggregate network was formed for each
of the 32 contexts. Each aggregate submission network consisted
of a set of edge scores, calculated by taking the mean of scores
submitted by teams for each edge. To ensure that edge scores were
comparable across teams, we scaled scores for each team before
aggregation so that the maximum edge score (across all 32 contexts for the experimental data task) had a value of one.
For the experimental data task, an aggregate prior network
was formed in an analogous manner to the aggregate submission
networks, using ten prior networks provided by teams (the prior
network submitted by Team2 was also used by several other teams
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but was included only once in the aggregation; Supplementary
Table 2). Individual prior networks, and therefore the aggregate
prior network, were not context specific.
Principal component analysis of context-specific aggregate
submission networks. The 32 context-specific aggregate submission networks for the network inference sub-challenge experimental data task were combined into a matrix E of edge scores in
which columns corresponded to contexts and rows corresponded
to edges (only network nodes common to all contexts were
considered for this analysis). Each row of matrix E contained
the scores for a specific edge in each of the contexts. Principal
component analysis was performed on this matrix using the
MATLAB function princomp.
Web-based community resource. A community resource has
been made available through the Synapse platform at https://www.
synapse.org/HPN_DREAM_Network_Challenge under the section titled “HPN-DREAM Community Resource.” This resource
includes all challenge data, participant submissions, participant
code, participant prior networks and crowdsourced aggregate networks. Code for scoring submissions is available as part of the
DREAMTools software package48 (Supplementary Note 11).
41. Neve, R.M. et al. A collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell 10, 515–527 (2006).
42. Garnett, M.J. et al. Systematic identification of genomic markers of drug
sensitivity in cancer cells. Nature 483, 570–575 (2012).
43. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive
modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012).
44. Hennessy, B.T. et al. A technical assessment of the utility of reverse
phase protein arrays for the study of the functional proteome in nonmicrodissected human breast cancers. Clin. Proteomics 6, 129–151 (2010).
45. Eduati, F. et al. Prediction of human population responses to toxic
compounds by a collaborative competition. Nat. Biotechnol. 33, 933–940
(2015).
46. Guitart-Pla, O., Kustagi, M., Rügheimer, F., Califano, A. & Schwikowski, B.
The Cyni framework for network inference in Cytoscape. Bioinformatics 31,
1499–1501 (2015).
47. Benjamini, Y., Krieger, A.M. & Yekutieli, D. Adaptive linear step-up
procedures that control the false discovery rate. Biometrika 93, 491–507
(2006).
48. Cokelaer, T. et al. DREAMTools: a Python package for scoring collaborative
challenges. F1000Research 4, 1030 (2015).

doi:10.1038/nmeth.3773

